Karen Wilson Los Altos, CA 94024Separation Agreement • December 22nd, 2004 • Virologic Inc • In vitro & in vivo diagnostic substances • California
As you know, following the Company’s recent merger with Aclara Biosciences, Inc. you resigned as Chief Financial Officer. In recognition of your service and contributions to the Company the Board of Directors has approved the following terms concerning your separation of employment (the “Agreement”), provided that you sign this Agreement.
